venetoclax,obinutuzumab
roche,abbvie
['obinu', 'lymsm', 'venetoclax', 'lymphoma']
congress #eha2022 | othman al-sawaf from the university hospital of cologne presented the transcriptomic characterization of mrd response &amp; non-response in pts treated with fixed-duration venetoclax-obinutuzumab. mrd status was strongly correlated with pfs and os #lymsm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm